278 related articles for article (PubMed ID: 24025977)
1. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
[TBL] [Abstract][Full Text] [Related]
2. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
3. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
Wunsch E; Szymanik B; Post M; Marlicz W; Mydłowska M; Milkiewicz P
Liver Int; 2011 Aug; 31(7):980-4. PubMed ID: 21733087
[TBL] [Abstract][Full Text] [Related]
4. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
Kircheis G; Hilger N; Häussinger D
Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
[TBL] [Abstract][Full Text] [Related]
5. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
6. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.
Moscucci F; Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Merli M; Riggio O
Liver Int; 2011 Nov; 31(10):1505-10. PubMed ID: 22093325
[TBL] [Abstract][Full Text] [Related]
7. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
8. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
[TBL] [Abstract][Full Text] [Related]
9. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
[TBL] [Abstract][Full Text] [Related]
10. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
Compañy L; Zapater P; Pérez-Mateo M; Jover R
Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
[TBL] [Abstract][Full Text] [Related]
11. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
[TBL] [Abstract][Full Text] [Related]
12. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
[TBL] [Abstract][Full Text] [Related]
13. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study.
Wunsch E; Naprawa G; Koziarska D; Milkiewicz M; Nowacki P; Milkiewicz P
Ann Hepatol; 2013; 12(3):448-55. PubMed ID: 23619262
[TBL] [Abstract][Full Text] [Related]
14. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
[TBL] [Abstract][Full Text] [Related]
15. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
[TBL] [Abstract][Full Text] [Related]
16. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
[TBL] [Abstract][Full Text] [Related]
18. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of the health-related quality of life of patients with minimal hepatic encephalopathy].
Bo ZJ; Qiu DK; Ma X; Zhang GS; Fan ZP; Huang YQ; Yu XF; Zeng MD
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):412-6. PubMed ID: 17594803
[TBL] [Abstract][Full Text] [Related]
20. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
